High Incidence of Hepatocellular Carcinomas After Synthetic Estrogen Administration in Syrian Golden Hamsters Fed α-Naphthoflavone: A New Tumor Model234
- 1 August 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 73 (2) , 543-547
- https://doi.org/10.1093/jnci/73.2.543
Abstract
An 80–100% incidence of multinodular hepatocellular carcinomas was observed in castrated male hamsters following synthetic estrogen treatment in the presence of 0.2–0.4% α-naph-thoflavone (ANF) in the diet after 8.5–10 months. Induction of these liver tumors was detected as early as 3.5–4.0 months in low frequency. Of the synthetic estrogens studied, ethynylestradiol (CAS: 57-63-6) was a more potent inducer of these hepatic carcinomas than either diethylstilbestrol (CAS: 56-53-1) or hexestrol (CAS: 84-16-2). ANF, considered an inhibitor of P450− dependent multisubstrate monooxygenases, did not produce any liver tumors when administered alone for up to 12 months. Neither concomitant androgen nor progesterone (CAS: 57-83-0) treatment resulted in any hepatic carcinomas in animals maintained on ANF. Moreover, β-naphthoflavone (CAS: 6051-87-2) treatment alone or in combination with these synthetic estrogens also resulted in no hepatic tumors. This new estrogen-induced liver tumor model could be useful to elucidate the causal relationship that exists between estrogenic hormones and hepatic tumors in humans.Keywords
This publication has 0 references indexed in Scilit: